Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
PET in Multiple Sclerosis.
Potential of Urinary Metabolites for Diagnosing Multiple Sclerosis.
Cannabidiol in Humans-The Quest for Therapeutic Targets.
Aerobic intensity and pacing pattern during the six-minute walk-test in patients with multiple sclerosis.
2010 McDonald criteria in a pediatric cohort: is positivity at onset associated with a more aggressive multiple sclerosis course?
Automatic brain MR images diagnosis based on edge fractal dimension and spectral energy signature.
Central adaptation after optic neuritis: Is the whole greater than the sum of its parts?
Neurotoxocarosis alters myelin protein gene transcription and expression.
Higher Circulating Levels of Chemokine CCL20 in Patients with Multiple Sclerosis: Evaluation of the Influences of Chemokine Gene Polymorphism, Gender, Treatment and Disease Pattern.
First case report of acute hemorrhagic leukoencephalitis following Plasmodium vivax infection.
Multiple sclerosis: Benefits of q-space imaging in evaluation of normal-appearing and periplaque white matter.
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression.
Serum-free spheroid suspension culture maintains mesenchymal stem cell proliferation and differentiation potential.
Ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, inhibits proliferation and differentiation of th17 cells.
Symptomatic treatment and management of multiple sclerosis.
Altered intrinsic regional spontaneous brain activity in patients with optic neuritis: a resting-state functional magnetic resonance imaging study.
An adult case of multiphasic disseminated encephalomyelitis manifesting with optic neuritis.
Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.
Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: A case report.
Long-term assessment of No Evidence of Disease Activity with natalizumab in relapsing multiple sclerosis.
Pixantrone: a B-cell-depleting immunosuppressant for multiple sclerosis patients with active disease.
Importance of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of the Treatment Efficacy in Multiple Sclerosis Patients with Acute Attacks.
Defining functional changes in the brain caused by targeted stereotaxic radiosurgery.
Cause and prevention of demyelination in a model multiple sclerosis lesion.
Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
519
520
521
522
523
524
525
526
527
…
next ›
last »